Stocks
ETFs
Options
Commodities
Crypto
Currency
Pro Newsletters
Research Tools
Daily Feeds
Calendars
Economic Indicators
Class Actions
Calculators
Education
About Us
Working with TipRanks
Follow Us
Hisamitsu Pharmaceutical Co Inc (HTSUF)
OTHER OTC:HTSUF
Holding HTSUF?
Track your performance easily
HTSUF Stock Chart & Stats
Day’s Range― - ―
52-Week Range$21.04 - $32.09
Previous CloseN/A
Volume30.00
Average Volume (3M)0.00
Market Cap
$2.35B
Enterprise Value$178.50B
Total Cash (Recent Filing)$113.05B
Total Debt (Recent Filing)$608.00M
Price to Earnings (P/E)21.4
Beta0.16
Next Earnings
Apr 10, 2025EPS EstimateN/A
Next Dividend Ex-Date
Feb 27, 2025Dividend Yield1.96%
Share Statistics
EPS (TTM)1.39
Shares Outstanding85,164,894
10 Day Avg. Volume0
30 Day Avg. Volume0
Standard Deviation0.12
R-Squared0.00857
Alpha-0.00380
Financial Highlights & Ratios
PEG RatioN/A
Price to Book (P/B)N/A
Price to Sales (P/S)2.46
Price to Cash Flow (P/CF)N/A
P/FCF Ratio0.00
Enterprise Value/Market Cap76.08
Enterprise Value/Revenue1.42
Enterprise Value/Gross Profit2.55
Enterprise Value/Ebitda10.49
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
Hisamitsu Pharmaceutical Co News
PremiumCompany Announcements
Hisamitsu Pharmaceutical Co. Reports Q2 GrowthPremiumPre-Earnings
Is HTSUF a Buy, Before Earnings?
PremiumCompany Announcements
Hisamitsu Pharma Reports Strong Q1 ResultsOptions Prices
Currently, No data available
---
Ownership Overview
―
Insiders
2.39% Mutual Funds
― Other Institutional Investors
88.22% Public Companies and
Individual Investors
HTSUF FAQ
What was Hisamitsu Pharmaceutical Co Inc’s price range in the past 12 months?
Hisamitsu Pharmaceutical Co Inc lowest stock price was $21.04 and its highest was $32.09 in the past 12 months.
What is Hisamitsu Pharmaceutical Co Inc’s market cap?
Hisamitsu Pharmaceutical Co Inc’s market cap is $2.35B.
When is Hisamitsu Pharmaceutical Co Inc’s upcoming earnings report date?
Hisamitsu Pharmaceutical Co Inc’s upcoming earnings report date is Apr 10, 2025 which is in 80 days.
How were Hisamitsu Pharmaceutical Co Inc’s earnings last quarter?
Currently, no data Available
Is Hisamitsu Pharmaceutical Co Inc overvalued?
According to Wall Street analysts Hisamitsu Pharmaceutical Co Inc’s price is currently Overvalued.
Does Hisamitsu Pharmaceutical Co Inc pay dividends?
Hisamitsu Pharmaceutical Co Inc does not currently pay dividends.
What is Hisamitsu Pharmaceutical Co Inc’s EPS estimate?
Hisamitsu Pharmaceutical Co Inc’s EPS estimate for its next earnings report is not yet available.
How many shares outstanding does Hisamitsu Pharmaceutical Co Inc have?
Hisamitsu Pharmaceutical Co Inc has 85,164,894 shares outstanding.
What happened to Hisamitsu Pharmaceutical Co Inc’s price movement after its last earnings report?
Currently, no data Available
Which hedge fund is a major shareholder of Hisamitsu Pharmaceutical Co Inc?
Currently, no hedge funds are holding shares in HTSUF
---
Company Description
Hisamitsu Pharmaceutical Co Inc
Hisamitsu Pharmaceutical Co., Inc. engages in the research, development, manufacture, and sale of pharmaceuticals and related products. Its products are sold under Salonpas, Salonsip, Mohrus, ByeBye-Fever, and Keplat brands. It also provides ethical pharmaceuticals, over- the-counter drugs, medical devices, health supplements, and topical analgesic products. The company was founded by Nihei Hisamitsu in 1847 and is headquartered in Tosu, Japan.
---
Technical Analysis
Sumitomo Dainippon Pharma Co
―
Astellas Pharma
―
Chugai Pharmaceutical Co
―
Shionogi & Co
―
Eisai Co
―
---